This informal session provides the perfect opportunity to connect with industry pioneers and key

opinion leaders in the oligonucleotide therapeutics field. Establish meaningful connections to build

upon at the rest of the conference and gain exclusive first-hand insights into the latest research

and developments driving progress in the space